Robert H Shoemaker. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Adenocarcinoma/drug therapyAntineoplastic Agents/pharmacologyBenzenesulfonates/pharmacologyCell Line, TumorClinical Trials as Topic/standardsDNA FingerprintingEsophageal Neoplasms/drug therapyHumansNational Institutes of Health (U.S.)Niacinamide/analogs & derivativesPhenylurea CompoundsPyridines/pharmacologySorafenibTandem Repeat SequencesUnited States
Substances： See more » Antineoplastic AgentsBenzenesulfonatesPhenylurea CompoundsPyridinesNiacinamideSorafenib
Year: 2010 PMID： 20075369 DOI： 10.1093/jnci/djp526
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506